Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Disulfiram
(D00131)
[1] Disulfiram[1] Disulfiram (D00131) 💬 [3] ALDH1B1,
ALDH2,
ALDH3A2 💬
[13] Alcoholic liver disease, Arginine and proline metabolism, Ascorbate and aldarate metabolism, Fatty acid degradation, Glycerolipid metabolism, Glycolysis / Gluconeogenesis, Histidine metabolism, Lysine degradation, Pantothenate and CoA biosynthesis, Pyruvate metabolism, Tryptophan metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬[3] 46, 90, 301 💬
2Disulfiram (DSF)
(D00131)
[1] Disulfiram[1] Disulfiram (D00131) 💬 [3] ALDH1B1,
ALDH2,
ALDH3A2 💬
[13] Alcoholic liver disease, Arginine and proline metabolism, Ascorbate and aldarate metabolism, Fatty acid degradation, Glycerolipid metabolism, Glycolysis / Gluconeogenesis, Histidine metabolism, Lysine degradation, Pantothenate and CoA biosynthesis, Pyruvate metabolism, Tryptophan metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬[1] 46 💬
3Oral disulfiram
(D00131)
[1] Disulfiram[1] Disulfiram (D00131) 💬 [3] ALDH1B1,
ALDH2,
ALDH3A2 💬
[13] Alcoholic liver disease, Arginine and proline metabolism, Ascorbate and aldarate metabolism, Fatty acid degradation, Glycerolipid metabolism, Glycolysis / Gluconeogenesis, Histidine metabolism, Lysine degradation, Pantothenate and CoA biosynthesis, Pyruvate metabolism, Tryptophan metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬[2] 90, 301 💬